Federated Deep Learning for Privacy-Preserving Cardiovascular Disease Risk Prediction

· Source: Machine Learning · Field: Health & Wellbeing — Artificial Intelligence & Machine Learning, Clinical Care & Medical Practice, Medical Devices & Health Technology · Depth: Expert, quick

Summary

A federated deep learning approach has been developed for privacy-preserving cardiovascular disease risk prediction, integrating two distinct population-based cohorts: Lifelines, with 148,230 participants, and the Rotterdam Study, comprising 10,155 participants. This method allows collaborative model development without sharing sensitive patient data, overcoming limitations posed by privacy regulations and dataset heterogeneity in size, population characteristics, and outcome definitions. The deep survival models, trained using federated learning, demonstrated improved predictive performance compared to locally trained models. Specifically, the C-statistic for the Rotterdam Study increased from 0.728 (95% CI: 0.717-0.739) to 0.739 (95% CI: 0.728-0.749), and for Lifelines, it rose from 0.783 (95% CI: 0.775-0.791) to 0.787 (95% CI: 0.780-0.792). These results highlight the potential of federated deep learning to enhance healthcare prediction while safeguarding patient privacy.

Key takeaway

For AI Scientists and Data Scientists developing healthcare predictive models, federated deep learning offers a robust solution to privacy constraints. You can improve model performance, as evidenced by C-statistic increases up to 0.739, by collaboratively training across diverse, distributed datasets like Lifelines and the Rotterdam Study without centralizing sensitive patient information. Consider implementing federated learning frameworks to enhance predictive accuracy while adhering to strict privacy regulations.

Key insights

Federated deep learning improves cardiovascular risk prediction across heterogeneous datasets while preserving patient privacy.

Principles

Method

The method involves training deep survival models using federated learning across two distinct population-based cohorts (Lifelines and Rotterdam Study) to predict cardiovascular disease risk without centralizing patient data.

In practice

Topics

Best for: CTO, VP of Engineering/Data, Director of AI/ML, AI Scientist, Research Scientist, Data Scientist

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine Learning.